Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiro Saito

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|July 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy OptimizationTomomasa Matsuo, Yu Ozawa, Atsunori Yorozu, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 15, 2007
[Questionnaire survey of peri-operative management of radical prostatectomy for the educational institutions of Japanese urological association]Kikuo Okamura, Hidehisa Soejima, Shiro Saito, et al.
Radiation Oncology (London, England)|November 19, 2015
Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort studyMasahiro Nakano, Atsunori Yorozu, Shiro Saito, et al.
Nature Communications|March 30, 2018
Publisher Correction: Observation of dark states in a superconductor diamond quantum hybrid systemXiaobo Zhu, Yuichiro Matsuzaki, Robert Amsüss, et al.
Physical Review Letters|August 29, 2014
Towards realizing a quantum memory for a superconducting qubit: storage and retrieval of quantum statesShiro Saito, Xiaobo Zhu, Robert Amsüss, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Brachytherapy|August 6, 2019
Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS)Hirofumi Koga, Seiji Naito, Hiromichi Ishiyama, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|May 11, 2019
Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)Nobumichi Tanaka, Atsunori Yorozu, Takashi Kikuchi, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Urology : Official Journal of the Japanese Urological Association|July 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy OptimizationTomomasa Matsuo, Yu Ozawa, Atsunori Yorozu, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 15, 2007
[Questionnaire survey of peri-operative management of radical prostatectomy for the educational institutions of Japanese urological association]Kikuo Okamura, Hidehisa Soejima, Shiro Saito, et al.
Radiation Oncology (London, England)|November 19, 2015
Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort studyMasahiro Nakano, Atsunori Yorozu, Shiro Saito, et al.
Nature Communications|March 30, 2018
Publisher Correction: Observation of dark states in a superconductor diamond quantum hybrid systemXiaobo Zhu, Yuichiro Matsuzaki, Robert Amsüss, et al.
Physical Review Letters|August 29, 2014
Towards realizing a quantum memory for a superconducting qubit: storage and retrieval of quantum statesShiro Saito, Xiaobo Zhu, Robert Amsüss, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Brachytherapy|August 6, 2019
Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS)Hirofumi Koga, Seiji Naito, Hiromichi Ishiyama, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|May 11, 2019
Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)Nobumichi Tanaka, Atsunori Yorozu, Takashi Kikuchi, et al.
Pageof 12